scholarly journals Cystic fibrosis is associated with an increased risk of Barrett's esophagus

2019 ◽  
Vol 18 (3) ◽  
pp. 425-429 ◽  
Author(s):  
Rita M. Knotts ◽  
Quinn S. Solfisburg ◽  
Claire Keating ◽  
Emily DiMango ◽  
Charles J. Lightdale ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Increased Risk

scholarly journals Probe-based confocal laser endomicroscopy and Barrett's esophagus – just a scientific toy or significant improvement in diagnosis?

2021 ◽  
Author(s):  
Luka Vranić ◽  
Tin Nadarević ◽  
Davor Štimac
Keyword(s):  
Diagnostic Accuracy ◽  
Real Time ◽  
Barrett’S Esophagus ◽  
Predictive Value ◽  
Barrett's Esophagus ◽  
High Reliability ◽  
Confocal Laser Endomicroscopy ◽  
Confocal Laser ◽  
Imaging Method ◽  
Increased Risk

Background: Barrett’s esophagus (BE) requires surveillance to identify potential neoplasia at early stage. Standard surveillance regimen includes random four-quadrant biopsies by Seattle protocol. Main limitations of random biopsies are high risk of sampling error, difficulties in histology interpretation, common inadequate classification of pathohistological changes, increased risk of bleeding and time necessary to acquire the final diagnosis. Probe-based confocal laser endomicroscopy (pCLE) has emerged as a potential tool with an aim to overcome these obvious limitations. Summary: pCLE represents real-time microscopic imaging method that offers evaluation of epithelial and subepithelial structures with 1000-fold magnification. In theory, pCLE has potential to eliminate the need for biopsy in BE patient. The main advantages would be real-time diagnosis and decision making, greater diagnostic accuracy and to evaluate larger area compared to random biopsies. Clinical pCLE studies in esophagus show high diagnostic accuracy and its high negative predictive value offers high reliability and confidence to exclude dysplastic and neoplastic lesions. However, it still cannot replace histopathology due to lower positive predictive value and sensitivity. Key messages: Despite promising results, its role in routine use in patients with Barrett’s esophagus remains questionable primarily due to lack of well-organized double-blind randomized trials.

scholarly journals Persistent confirmed low-grade dysplasia in Barrett's esophagus is a risk factor for progression to high-grade dysplasia and adenocarcinoma in a US Veterans cohort

2019 ◽  
Author(s):  
K Y Song ◽  
A J Henn ◽  
A A Gravely ◽  
H Mesa ◽  
S Sultan ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Independent Risk Factor ◽  
High Grade Dysplasia ◽  
Low Grade ◽  
High Grade ◽  
Increased Risk ◽  
Low Grade Dysplasia

SUMMARY Patients with Barrett's esophagus (BE) and low-grade dysplasia (LGD) are at increased risk of esophageal adenocarcinoma (EAC), although many regress to nondysplastic BE. This has significant clinical importance for patients being considered for endoscopic eradication therapy. Our aim is to determine the risk for progression in patients with confirmed persistent LGD. We performed a single-center retrospective cohort study of patients with BE and confirmed LGD between 2006 and 2016. Confirmed LGD was defined as LGD diagnosed by consensus conference with an expert GI pathologist or review by an expert GI pathologist and persistence as LGD present on subsequent endoscopic biopsy. The primary outcome was the incidence rate of HGD (high-grade dysplasia)/EAC. Secondary outcomes included risk factors for dysplastic progression. Risk factors for progression were assessed using univariate and multivariate analysis with logistic regression. Of 69 patients (mean age 65.2 years) with confirmed LGD were included. In total, 16 of 69 patients (23.2%) with LGD developed HGD/EAC during a median follow-up of 3.74 years (IQR, 1.24–5.45). For persistent confirmed LGD, the rate was 6.44 (95% confidence interval (CI), 2.61–13.40) compared to 2.61 cases per 100 patient-years (95% CI, 0.83–6.30) for nonpersistent LGD. Persistent LGD was found in only 29% of patients. Persistent LGD was an independent risk factor for the development of HGD/EAC (OR 4.18; [95% CI, 1.03–17.1]). Persistent confirmed LGD, present in only 1/3 of patients, was an independent risk factor for the development of HGD/EAC. Persistence LGD may be useful in decision making regarding the management of BE.

scholarly journals Sa1224 THE PRESENCE OF OBSTRUCTIVE SLEEP APNEA IS ASSOCIATED WITH INCREASED RISK FOR GERD AND BARRETT'S ESOPHAGUS

2020 ◽  
Vol 158 (6) ◽  
pp. S-318-S-319
Author(s):  
Ahmad Alkaddour ◽  
Muhammad Talal Sarmini ◽  
Mohammad Maysara Asfari ◽  
Kenneth J. Vega
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Obstructive Sleep ◽  
Increased Risk

scholarly journals Increased Risk for Persistent Intestinal Metaplasia in Patients With Barrett's Esophagus and Uncontrolled Reflux Exposure Before Radiofrequency Ablation

2012 ◽  
Vol 143 (3) ◽  
pp. 576-581 ◽  
Author(s):  
Kumar Krishnan ◽  
John E. Pandolfino ◽  
Peter J. Kahrilas ◽  
Laurie Keefer ◽  
Lubomyr Boris ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Intestinal Metaplasia ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Increased Risk

Increased Risk of Barrett's Esophagus Among Individuals Born Preterm or Small for Gestational Age

2013 ◽  
Vol 11 (7) ◽  
pp. 790-794 ◽  
Author(s):  
Lina Forssell ◽  
Sven Cnattingius ◽  
Matteo Bottai ◽  
Anna–Karin Edstedt Bonamy ◽  
Jesper Lagergren ◽  
...  
Keyword(s):  
Barrett’S Esophagus ◽  
Gestational Age ◽  
Small For Gestational Age ◽  
Barrett's Esophagus ◽  
Increased Risk

Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma

2012 ◽  
Vol 47 (12) ◽  
pp. 1422-1428 ◽  
Author(s):  
Vivianda Menke ◽  
Katinka P.M. Van Zoest ◽  
Leon M.G. Moons ◽  
Raymond G.J. Pot ◽  
Peter D. Siersema ◽  
...  
Keyword(s):  
Barrett’S Esophagus ◽  
Esophageal Adenocarcinoma ◽  
Barrett's Esophagus ◽  
Increased Risk
Sign in / Sign up

Export Citation Format

Share Document